Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 9335505)

1.

Smad6 inhibits signalling by the TGF-beta superfamily.

Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K.

Nature. 1997 Oct 9;389(6651):622-6.

PMID:
9335505
2.

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P.

EMBO J. 1997 Sep 1;16(17):5353-62.

4.

Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line.

Shimizu A, Kato M, Nakao A, Imamura T, ten Dijke P, Heldin CH, Kawabata M, Shimada S, Miyazono K.

Genes Cells. 1998 Feb;3(2):125-34.

PMID:
9605406
5.
6.

The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.

Zhang Y, Musci T, Derynck R.

Curr Biol. 1997 Apr 1;7(4):270-6.

7.

Expression of TGF-beta related Smad proteins in human epithelial skin tumors.

Lange D, Persson U, Wollina U, ten Dijke P, Castelli E, Heldin CH, Funa K.

Int J Oncol. 1999 Jun;14(6):1049-56.

PMID:
10339656
8.

Smad6 functions as an intracellular antagonist of some TGF-beta family members during Xenopus embryogenesis.

Nakayama T, Gardner H, Berg LK, Christian JL.

Genes Cells. 1998 Jun;3(6):387-94.

PMID:
9734784
9.

Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.

Mochizuki T, Miyazaki H, Hara T, Furuya T, Imamura T, Watabe T, Miyazono K.

J Biol Chem. 2004 Jul 23;279(30):31568-74. Epub 2004 May 17.

10.

Induction of Smad6 mRNA by bone morphogenetic proteins.

Takase M, Imamura T, Sampath TK, Takeda K, Ichijo H, Miyazono K, Kawabata M.

Biochem Biophys Res Commun. 1998 Mar 6;244(1):26-9.

PMID:
9514869
12.

A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.

Kato Y, Habas R, Katsuyama Y, Näär AM, He X.

Nature. 2002 Aug 8;418(6898):641-6. Epub 2002 Jul 24.

PMID:
12167862
13.
14.

Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).

Pardali K, Kowanetz M, Heldin CH, Moustakas A.

J Cell Physiol. 2005 Jul;204(1):260-72.

PMID:
15690394
15.

Endogenous patterns of TGFbeta superfamily signaling during early Xenopus development.

Faure S, Lee MA, Keller T, ten Dijke P, Whitman M.

Development. 2000 Jul;127(13):2917-31.

16.

Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.

Souchelnytskyi S, Tamaki K, Engström U, Wernstedt C, ten Dijke P, Heldin CH.

J Biol Chem. 1997 Oct 31;272(44):28107-15.

17.

The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.

Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K.

J Cell Biol. 2001 Dec 10;155(6):1017-27. Epub 2001 Dec 10.

18.

New insights into TGF-beta-Smad signalling.

ten Dijke P, Hill CS.

Trends Biochem Sci. 2004 May;29(5):265-73. Review.

PMID:
15130563
19.

The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.

Poncelet AC, de Caestecker MP, Schnaper HW.

Kidney Int. 1999 Oct;56(4):1354-65.

20.

The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling.

Attisano L, Silvestri C, Izzi L, Labbé E.

Mol Cell Endocrinol. 2001 Jun 30;180(1-2):3-11. Review.

PMID:
11451566
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk